Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-09-16

FDA Approved: ALOSETRON HYDROCHLORIDE — Original Application (Eywa Pharma Inc)

View source ↗

Summary

FDA approved Eywa Pharma Inc's original ANDA for alosetron hydrochloride, a generic version of the IBS with diarrhea treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alosetron hydrochloride (Alosetron hydrochloride)

Snippet

ORIG AP for ALOSETRON HYDROCHLORIDE (ALOSETRON HYDROCHLORIDE)